Iridex Director Granted 68,000 Stock Options at $0.94 Strike Price
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Iridex Corp director William M. Moore received two stock option grants on June 13, 2025, as reported in this Form 4 filing:
- First grant: 53,000 stock options with exercise price of $0.94, vesting fully on either the one-year anniversary or 2026 annual meeting
- Second grant: 15,000 stock options with exercise price of $0.94, vesting monthly over four years starting July 13, 2025
Both options were granted under the company's 2008 Equity Incentive Plan and expire on June 13, 2032. The grants are exempt under Rule 16b-3. This compensation structure aligns the director's interests with shareholders through both short-term and long-term vesting schedules. The low exercise price suggests the stock may be trading near historical lows.
Positive
- Director William Moore was granted significant stock options totaling 68,000 shares at $0.94 per share, demonstrating long-term alignment with shareholder interests through multi-year vesting schedules
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (right to buy) | 53,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock (right to buy) | 15,000 | $0.00 | $0.00 |
Footnotes (3)
- F1. This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3.
- F2. All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders.
- F3. The shares are subject to vesting according to the following schedule: 1/48 of the total number of shares subject to the option shall vest on July 13, 2025, and each month thereafter, such that the option shall be fully vested on the earlier of (i) the four-year anniversary of the grant date or (ii) the Company's 2029 annual meeting of stockholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did IRIX director William Moore receive on June 13, 2025?
What is the exercise price of IRIX stock options granted to William Moore?
When do William Moore's IRIX stock options expire?
What is the vesting schedule for William Moore's 15,000 IRIX stock options?
Who filed this Form 4 for IRIX director William Moore?
AI-generated analysis. How Rhea-AI works. Not financial advice.